Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
NCT ID: NCT03851497
Last Updated: 2021-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1200 participants
OBSERVATIONAL
2019-01-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography
NCT03708978
Multi-center Study of Deep Learning AI in Breast Mass
NCT05443672
Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.
NCT04270032
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer
NCT05243121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Had breast lesions detected by ultrasound.
* No clinical symptoms such as nipple discharge, while breast lesions were not palpable.
* Received breast surgery within one week of ultrasound examination.
* Agreed to participant in this study and signed informed consent.
Exclusion Criteria
* Patients who were pregnant or lactating.
* Patients who were undergoing neoadjuvant treatment.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Beijing Hospital
OTHER_GOV
Beijing Chao Yang Hospital
OTHER
Beijing Zhongguancun Hospital
UNKNOWN
Peking University Aerospace Center Hospital
OTHER
Beijing Anzhen Community Health Service Center
UNKNOWN
First Hospital of Tsinghua University
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Henan Provincial People's Hospital
OTHER
Third Affiliated Hospital of Zhengzhou University
OTHER
Xinxiang Central Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
First Hospital of China Medical University
OTHER
Shengjing Hospital
OTHER
Liaoning Cancer Hospital & Institute
OTHER
West China Hospital
OTHER
Sichuan Provincial People's Hospital
OTHER
Yan'an Hospital of Kunming City
UNKNOWN
Xi'an Central Hospital
OTHER
Ningxia Medical University
OTHER
First Hospital of Shijiazhuang City
OTHER
Chengde Central Hospital
OTHER_GOV
Qinghai Province Cancer Hospital
UNKNOWN
Gansu Cancer Hospital
OTHER
Shanghai Zhongshan Hospital
OTHER
Ruijin Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Qingdao Central Hospital
OTHER
Jining First People's Hospital
OTHER
Linyi Tumour Hospital
OTHER
The First Affiliated Hospital of Shanxi Medical University
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
Second Hospital of Jilin University
OTHER
The Second Hospital of the West Coast New Area of Qingdao
UNKNOWN
Fudan University
OTHER
Tongji Hospital
OTHER
Jiangsu Province People's Hospital
UNKNOWN
Peking University Shougang Hospital
OTHER
Gansu Jiugang Hospital
UNKNOWN
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-detect 2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.